|
|
||||||||

*
Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany; and
Serono Pharmaceutical Research Institute, Geneva, Switzerland
Cytokines and chemokines are responsible for the attraction and
activation of eosinophils in allergic and inflammatory diseases.
Whereas cytokines such as IL-3, IL-5, and GM-CSF activate eosinophils
via heterodimeric receptors containing a distinct
-chain (binding
domain) and a common
-chain (signaling domain), chemokines such as
eotaxin activate eosinophils via seven-transmembrane Gi
protein-coupled CCRs. Recent studies have demonstrated the importance
of CCR3 on human eosinophils that undergo receptor recycling after
chemokine activation, but the modulation of this receptor by cytokines
has not yet been addressed. In this study, we demonstrate that IL-3
induces a dose- and time-dependent down-regulation of CCR3 from the
surface of human eosinophils comparable to the CCR3-specific ligand
eotaxin, whereas IL-5, GM-CSF, IL-4, IL-10, IL-13, IFN-
, and TNF-
had no effect. Maximal down-regulation of CCR3 in response to IL-3 was
reached at 24 h. Reduction of CCR3 surface protein in response to
IL-3 could be prevented by an anti-IL-3 mAb and was neither due to
the release of CC chemokines nor to nonspecific binding of IL-3 to
CCR3. Moreover, down-regulation was prevented by phenylarsine
oxide, a nonspecific inhibitor of receptor internalization.
After 24 h, IL-3-induced decrease of CCR3 surface expression
correlated with diminished mRNA expression, suggesting a
transcriptional regulation mechanism. Since wortmannin partially
inhibited IL-3- but not eotaxin-induced CCR3 down-regulation, receptor
down-modulation seems to underlie different signaling events.
Therefore, these data suggest a novel role for the cytokine IL-3 in the
activation process of eosinophils and its predominant chemokine
receptor CCR3.
This article has been cited by other articles:
![]() |
U. Forssmann, C. Stoetzer, M. Stephan, C. Kruschinski, T. Skripuletz, J. Schade, A. Schmiedl, R. Pabst, L. Wagner, T. Hoffmann, et al. Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo J. Immunol., July 15, 2008; 181(2): 1120 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, B. Fuchs, S. Schulz-Maronde, A. Heitland, S. E. Escher, M. Mack, H.-C. Tillmann, A. Braun, W.-G. Forssmann, J. Elsner, et al. Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation J. Leukoc. Biol., March 1, 2008; 83(3): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munitz, I. Bachelet, R. Eliashar, M. Khodoun, F. D. Finkelman, M. E. Rothenberg, and F. Levi-Schaffer CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils J. Immunol., July 1, 2006; 177(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, S. Schulz-Maronde, C. Kutzleb, R. Richter, W.-G. Forssmann, A. Kapp, U. Forssmann, and J. Elsner Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1 J. Leukoc. Biol., November 1, 2005; 78(5): 1175 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Forssmann, I. Hartung, R. Balder, B. Fuchs, S. E. Escher, N. Spodsberg, Y. Dulkys, M. Walden, A. Heitland, A. Braun, et al. n-Nonanoyl-CC Chemokine Ligand 14, a Potent CC Chemokine Ligand 14 Analogue That Prevents the Recruitment of Eosinophils in Allergic Airway Inflammation J. Immunol., September 1, 2004; 173(5): 3456 - 3466. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Erpenbeck, A. Hagenberg, Y. Dulkys, J. Elsner, R. Balder, H. Krentel, M. Discher, A. Braun, N. Krug, and J. M. Hohlfeld Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 578 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qiuping, L. Qun, H. Chunsong, Z. Xiaolian, H. Baojun, Y. Mingzhen, L. Chengming, H. Jinshen, G. Qingping, Z. Kejian, et al. Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia Cancer Res., October 1, 2003; 63(19): 6469 - 6477. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gregory, A. Kirchem, S. Phipps, P. Gevaert, C. Pridgeon, S. M. Rankin, and D. S. Robinson Differential Regulation of Human Eosinophil IL-3, IL-5, and GM-CSF Receptor {alpha}-Chain Expression by Cytokines: IL-3, IL-5, and GM-CSF Down-Regulate IL-5 Receptor {alpha} Expression with Loss of IL-5 Responsiveness, but Up-Regulate IL-3 Receptor {alpha} Expression J. Immunol., June 1, 2003; 170(11): 5359 - 5366. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |